Janux Therapeutics, Inc. · NASDAQ:JANX
RA Capital Nexus Fund II, L.P. received 5,500 Janux Therapeutics, Inc. shares as an award (Form 4)
Traded Jun 11, 2026 · Filed Jun 12, 2026
On Jun 11, 2026, RA Capital Nexus Fund II, L.P. (Director) received 5,500 Janux Therapeutics, Inc. shares as an award, leaving 11,750 shares. Filed Jun 12, 2026 (Form 4).
- Awarded
- 5,500 shares
- Holding after
- 11,750 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock | Award | 5,500 | 11,750 | Indirect |
Source
Related
- Janux Therapeutics, Inc.
- RA Capital Nexus Fund II, L.P.
- Janux Therapeutics, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Campbell David Alan · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Campbell David Alan · Jul 10, 2026